CVI Accepts, published online ahead of print on 19 November 2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martins, T. B.
Right arrow Articles by Litwin, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martins, T. B.
Right arrow Articles by Litwin, C. M.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00351-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Comparison of a Multiplexed HSV Type-specific IgG Serology Assay to ELISA, Immunoblot and Western Blot

Thomas B. Martins*, Ryan J. Welch*, Harry R. Hill, and Christine M. Litwin

Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, Salt Lake City, UT; and the Department of Pathology, Pediatrics and Medicine, University of Utah School of Medicine, Salt Lake City, UT

* To whom correspondence should be addressed. Email: martintb{at}aruplab.com. ryan.welch{at}aruplab.com.


arrow
Abstract

The human herpes simplex virus (HSV) is highly pathogenic with infections caused by two distinct antigenic types, HSV-1 and HSV-2. Differentiation of antibodies to these specific antigens can provide useful information in the diagnosis of subclinical or undiagnosed HSV type 2 infections, as well as in reducing the risk of maternal transfer of HSV to the neonate. In this study, a multiplex assay capable of concurrent detection of HSV-1 and 2 IgG antibodies was compared to immunoblot, ELISA and Western blot assays. Agreement of the multiplex assay was 95% or greater (n=332) for both HSV-1 and 2 compared to the three assays. Sensitivity for HSV-1 ranged from 94.9- 97.9% with specificities of 93-97%. For HSV-2, the sensitivity and specificity ranges were 92.6-98.9% and 98.3-98.7%, respectively. Our studies show that the multiplexed microsphere-based assay offers a sensitive and specific alternative method for the detection HSV-1 and 2 type specific antibodies. Advantages of the multiplex assay include multiple results per assay, the inclusion of internal controls for each specimen, and higher throughput of results.